Artículos de revistas sobre el tema "Hematological malignancie"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Hematological malignancie".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Miao, Miao, Wu Depei, Aining Sun, Ying Wang, Lingzhi Yan y Qian Wu. "The Efficacy and Safety of Recombinant Human Thrombopoietin in Patients with Hematological Malgnancies After Allogeneic Hematopoietic Stem Cell Transplantation". Blood 118, n.º 21 (18 de noviembre de 2011): 4565. http://dx.doi.org/10.1182/blood.v118.21.4565.4565.
Texto completoDong, L., X.-Y. Zhai, Y.-L. Yang, L. Wang, Y. Zhou, H.-Y. Shi, B.-H. Tang et al. "P110 Population pharmacokinetics and dosing optimisation of imipenem in children with haematological malignancie". Archives of Disease in Childhood 104, n.º 6 (17 de mayo de 2019): e63.3-e63. http://dx.doi.org/10.1136/archdischild-2019-esdppp.148.
Texto completoZinzani, Pier Luigi, Enrico Derenzini, Cinzia Pellegrini, Luigi Rigacci, Alberto Fabbri, Federica Quirini, Vittorio Stefoni et al. "Fludarabine and Mitoxantrone Followed by Yttrium-90 Ibritumumab Tiuxetan in Untreated Patients with Follicular Lymphoma. Long Term Efficacy and Toxicity Results of the FLUMIZ Trial." Blood 118, n.º 21 (18 de noviembre de 2011): 1604. http://dx.doi.org/10.1182/blood.v118.21.1604.1604.
Texto completoClemmensen, Signe B., Jennifer R. Harris, Jonas Mengel-From, Wagner H. Bonat, Henrik Frederiksen, Jaakko Kaprio y Jacob v. B. Hjelmborg. "Familial Risk and Heritability of Hematologic Malignancies in the Nordic Twin Study of Cancer". Cancers 13, n.º 12 (16 de junio de 2021): 3023. http://dx.doi.org/10.3390/cancers13123023.
Texto completoAsare, Mariette, Jeanne E. Hendrickson y Christopher A. Tormey. "Determination of Red Blood Cell Alloimmunization Rates in Transfused Patients with Hematologic and Oncologic Malignancies". Blood 128, n.º 22 (2 de diciembre de 2016): 1463. http://dx.doi.org/10.1182/blood.v128.22.1463.1463.
Texto completoLiao, Yongkang, Shijun Xiong, Zaid Ur Rehman, Xiaoli He, Hongling Peng, Jing Liu y Shuming Sun. "The Research Advances of Aptamers in Hematologic Malignancies". Cancers 15, n.º 1 (1 de enero de 2023): 300. http://dx.doi.org/10.3390/cancers15010300.
Texto completoYang, Xiao-Jing, Ya-Ming Xi y Zi-Jian Li. "Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy". BioMed Research International 2019 (28 de marzo de 2019): 1–7. http://dx.doi.org/10.1155/2019/4860268.
Texto completoRen, Anqi, Xiqin Tong, Na Xu, Tongcun Zhang, Fuling Zhou y Haichuan Zhu. "CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities". Vaccines 11, n.º 1 (12 de enero de 2023): 165. http://dx.doi.org/10.3390/vaccines11010165.
Texto completoYAEGASHI, HIROSHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, YOSHIFUMI KADONO, TOMOYUKI MAKINO, KANAME YAMASHITA, KOUSHIRO OHTSUBO, HIROKO IKEDA y ATSUSHI MIZOKAMI. "Survival Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Retrospective Single-institutional Experience". Cancer Diagnosis & Prognosis 2, n.º 3 (3 de mayo de 2022): 352–59. http://dx.doi.org/10.21873/cdp.10116.
Texto completoKrishnan, Gayathri y Anupam Pande. "985. Fusarium Infections in Patients with Hematological Malignancies". Open Forum Infectious Diseases 8, Supplement_1 (1 de noviembre de 2021): S583—S584. http://dx.doi.org/10.1093/ofid/ofab466.1179.
Texto completoIftikhar, Raheel y Uzma Zaidi. "Interim-Guidelines for COVID-19 Vaccination in Hematological Malignancies and Hematopoietic Stem Cell Transplant Recipients". National Journal of Health Sciences 6, n.º 1 (29 de octubre de 2021): 38–43. http://dx.doi.org/10.21089/njhs.61.0038.
Texto completoAndi Cahyadi, Esthy Poespitaningtyas, Diah Kusuma Arumsari, Maria Christina Shanty Larasati, Mia Ratwita Andarsini y I Dewa Gede Ugrasena. "Region Variation of Hematological Malignancies and Solid Tumors in Children in East Java". Asian Journal of Health Research 2, n.º 1 (7 de marzo de 2023): 27–33. http://dx.doi.org/10.55561/ajhr.v2i1.71.
Texto completoSalem, Ahmed Ebada, Harsh R. Shah, Matthew F. Covington, Bhasker R. Koppula, Gabriel C. Fine, Richard H. Wiggins, John M. Hoffman y Kathryn A. Morton. "PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies". Cancers 14, n.º 23 (30 de noviembre de 2022): 5941. http://dx.doi.org/10.3390/cancers14235941.
Texto completoAbbagoni, Sujith, Thuy Le, Locke J. Bryan, Mohammad A. H. Mian, Danielle Bradshaw, Ashley D. Fox, Anand P. Jillella et al. "Central Line Associated Bloodstream Infection Rate Among Hematologic Malignant Patients Who Received Antimicrobial Prophylaxis in the Inpatient Setting". Blood 138, Supplement 1 (5 de noviembre de 2021): 4390. http://dx.doi.org/10.1182/blood-2021-154524.
Texto completoTsering, Lama Tamang, Sindhu Barola y Abhinav B. Chandra. "Assessing Bacterial Isolates in Bloodstream Infections and Trend of the Antimicrobial Resistance in the Hematological and Solid Malignancies". Blood 126, n.º 23 (3 de diciembre de 2015): 5628. http://dx.doi.org/10.1182/blood.v126.23.5628.5628.
Texto completoSud, Amit, Subhayan Chattopadhyay, Hauke Thomsen, Kristina Sundquist, Jan Sundquist, Richard S. Houlston y Kari Hemminki. "Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk". Blood 134, n.º 12 (8 de agosto de 2019): 960–69. http://dx.doi.org/10.1182/blood.2019001362.
Texto completoBanerjee, Suvankar, Sk Abdul Amin y Tarun Jha. "Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors". Current Chemical Biology 15, n.º 1 (27 de abril de 2021): 19–49. http://dx.doi.org/10.2174/2212796815666210203104446.
Texto completoGhimire, Krishna B. y Binay K. Shah. "Second Primary Malignancy in Diffuse Large B Cell Lymphoma (DLBCL)". Blood 124, n.º 21 (6 de diciembre de 2014): 2606. http://dx.doi.org/10.1182/blood.v124.21.2606.2606.
Texto completoDar, Lior, Niv Ben-Shabat, Shmuel Tiosano, Abdulla Watad, Dennis McGonagle, Doron Komaneshter, Arnon Cohen, Nicola Luigi Bragazzi y Howard Amital. "The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study". International Journal of Environmental Research and Public Health 18, n.º 14 (16 de julio de 2021): 7595. http://dx.doi.org/10.3390/ijerph18147595.
Texto completoOrhan, Bedrettin, Fahir Özkalemkaş, Vildan Özkocaman, Büşra Gürbüz, Tuba Ersal, İbrahim Ethem Pınar, Cumali Yalçın et al. "THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES". Mediterranean Journal of Hematology and Infectious Diseases 14, n.º 1 (29 de junio de 2022): e2022051. http://dx.doi.org/10.4084/mjhid.2022.051.
Texto completoShrestha, Amar Narayan, Sunil Kumar Singh, Rajiv Kumar Deo, Rinku Joshi, Ayusha Poudel, Barun Babu Aryal y Anurag Adhikari. "Pattern of hematological malignancy in a tertiary level hospital in Kathmandu". Journal of Pathology of Nepal 9, n.º 1 (29 de marzo de 2019): 1457–59. http://dx.doi.org/10.3126/jpn.v9i1.23355.
Texto completoHanif, Umair, Mughees Ahmed y Imran Hanif. "HEMATOLOGICAL MALIGNANCIES". Professional Medical Journal 22, n.º 03 (10 de marzo de 2015): 349–52. http://dx.doi.org/10.29309/tpmj/2015.22.03.1354.
Texto completoBrenner, Malcolm K. "Hematological malignancies". FASEB Journal 11, n.º 8 (julio de 1997): 640–48. http://dx.doi.org/10.1096/fasebj.11.8.9240966.
Texto completoGiagounidis, A. A. N., U. Germing, J. S. Wainscoat, J. Boultwood y C. Aul. "Hematological Malignancies". Hematology 9, n.º 4 (agosto de 2004): 271–77. http://dx.doi.org/10.1080/10245330410001723824.
Texto completoBueso-Ramos, Carlos E., Alessandra Ferrajoli, L. Jeffrey Medeiros, Michael J. Keating y Zeev Estrov. "Hematological Malignancies". Hematology 9, n.º 4 (agosto de 2004): 279–86. http://dx.doi.org/10.1080/10245330410001727046.
Texto completoPrajapati, Zankhana, Mayur Kokani y R. Gonsai. "Clinicoepidemiological profile of hematological malignancies in pediatric age group in Ahmedabad". Asian Journal of Oncology 03, n.º 01 (enero de 2017): 054–58. http://dx.doi.org/10.4103/2454-6798.209330.
Texto completoCole, Craig E., Alyson R. Haugen, Michelle A. Mathiason y Vicki L. McHugh. "Screening for Psychosocial Distress in Patients with Hematological Malignancies and Identifying Specific Factors That Cause Distress throughout Stage of Disease". Blood 118, n.º 21 (18 de noviembre de 2011): 2086. http://dx.doi.org/10.1182/blood.v118.21.2086.2086.
Texto completoFolci, Marco, Giacomo Ramponi, Dana Shiffer, Aurora Zumbo, Michele Agosti y Enrico Brunetta. "ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives". Journal of Immunology Research 2019 (6 de mayo de 2019): 1–9. http://dx.doi.org/10.1155/2019/1732175.
Texto completoBennett, Dimitri, Nittaya Suppapanya y Kelly Grotzinger. "Thrombocytopenia in hematologic malignancy and solid tumors in the United States." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): e12001-e12001. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e12001.
Texto completoAzhar, Hajra, Hafiz Muhammad Matloob, Nida Khalid, Ayesha Rahman, Javeria Afzal y Najma Qureshi. "Clinico-Hematological Pattern of Haematological Malignancies in Patients Referred for Bone Marrow Examination". Pakistan Journal of Medical and Health Sciences 17, n.º 1 (31 de enero de 2023): 168–70. http://dx.doi.org/10.53350/pjmhs2023171168.
Texto completoLim, Tristan L., David B. Lieberman, Adam R. Davis, Ryan Hausler, Ashkan Bigdeli, Yimei Li, Jacquelyn Powers et al. "Germline POT1 Variants Can Predispose to a Variety of Hematologic Neoplasms". Blood 136, Supplement 1 (5 de noviembre de 2020): 2–4. http://dx.doi.org/10.1182/blood-2020-134160.
Texto completoPrusila, Roosa Enni Inkeri, Marc Sorigue, Aleksi Postila, Petteri Salmi, Taru Tanhua, Susanna Tikkanen, Sakari Kakko et al. "Risk of Secondary Hematological Malignancies in Patients with Follicular Lymphoma: A Retrospective Analysis of 1045 Patients Treated in the Rituximab Era". Blood 132, Supplement 1 (29 de noviembre de 2018): 5330. http://dx.doi.org/10.1182/blood-2018-99-110129.
Texto completoCeken, Sabahat, Habip Gedik, Gulsen Iskender, Meryem Demirelli, Duygu Mert, Goknur Yapar Toros, Tugce Nur Yigenoglu, Fevzi Altuntas, Berna Oksuzoglu y Mustafa Ertek. "Evaluation of Risk Factors for Mortality in Febrile Neutropenia". Journal of Infection in Developing Countries 14, n.º 08 (31 de agosto de 2020): 886–92. http://dx.doi.org/10.3855/jidc.12520.
Texto completoBuppanharun, Jirawat y Jakapat Vanichanan. "1378. Clinical Characteristics of Tuberculosis Among Patients with Cancer in an Endemic Country". Open Forum Infectious Diseases 6, Supplement_2 (octubre de 2019): S500—S501. http://dx.doi.org/10.1093/ofid/ofz360.1242.
Texto completoSaleh, Khalid S., Jabbar S. Hassan, Ali Zaidan y Rija A. Abdul- Ridha. "The Impact of Vaccination on Severity of COVID-19 Illness in Hematologic Malignancies Patients". Bionatura 7, n.º 2 (15 de mayo de 2022): 1–6. http://dx.doi.org/10.21931/rb/2022.07.02.51.
Texto completoPak, Daniel M. y Maria S. Tretiakova. "An Unusual Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm as a Testicular Tumor". Case Reports in Pathology 2019 (7 de octubre de 2019): 1–4. http://dx.doi.org/10.1155/2019/9196167.
Texto completoSinghrao, Ruby, Lisha Capucion, Shikha Chugh, Shuba Krishna, Adama Parham, Amy Harrell, Ranga Yerram, John Duncan y Manana Javey. "Abstract 5236: Clinical evaluation of somatic genomic alteration annotation for hematological malignancies using tertiary analysis software". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 5236. http://dx.doi.org/10.1158/1538-7445.am2022-5236.
Texto completoOktariana, Desi, Legiran Legiran, Phey Liana, Kemas Y. Rahadiyanto, Gita D. Prasasty, Evi Lusiana y Nia S. Tamzil. "Transplantasi Stem Cell untuk Keganasan Hematologi". eJournal Kedokteran Indonesia 10, n.º 2 (5 de septiembre de 2022): 186–93. http://dx.doi.org/10.23886/ejki.10.123.186-93.
Texto completoCooper, Kathrine A., Jonathan Lattell, Beverly Gonzalez, Stephanie Kliethermes y Sucha Nand. "Prevalence of Multiple Primary Hematologic Malignancies Seen at a Tertiary Care Center". Blood 126, n.º 23 (3 de diciembre de 2015): 5017. http://dx.doi.org/10.1182/blood.v126.23.5017.5017.
Texto completoDurand-Onaylı, Valerie, Theresa Haslauer, Andrea Härzschel y Tanja Hartmann. "Rac GTPases in Hematological Malignancies". International Journal of Molecular Sciences 19, n.º 12 (14 de diciembre de 2018): 4041. http://dx.doi.org/10.3390/ijms19124041.
Texto completoKnight, Ann, Karin Hjorton, Christer Sundström, Martin Höglund, Carin Backlin, Karin E. Smedby, Johan Askling y Eva Baecklund. "Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome". Journal of Rheumatology 42, n.º 4 (1 de febrero de 2015): 690–94. http://dx.doi.org/10.3899/jrheum.141104.
Texto completoUYSAL, Elmas, Fatih SEĞMEN, Gamze KILIÇARSLAN y Deniz ERDEM. "The effect of malignancy on prognosis in ICU patients with COVID-19". Anatolian Current Medical Journal 4, n.º 3 (26 de julio de 2022): 284–89. http://dx.doi.org/10.38053/acmj.1117598.
Texto completoDimopoulos, M. A., E. Kastritis y A. Anagnostopoulos. "Hematological malignancies: myeloma". Annals of Oncology 17 (septiembre de 2006): x136—x143. http://dx.doi.org/10.1093/annonc/mdl251.
Texto completoDufva, Olli, Petri Pölönen, Oscar Brück, Mikko A. Keränen, Juha Mehtonen, Sanna M. Siitonen, Suvi-Katri Leivonen et al. "Immunogenomic Landscape of Hematological Malignancies". Blood 132, Supplement 1 (29 de noviembre de 2018): 2596. http://dx.doi.org/10.1182/blood-2018-99-118335.
Texto completoJacobs, Chaja F., Eric Eldering y Arnon P. Kater. "Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19". Blood Advances 5, n.º 3 (9 de febrero de 2021): 913–25. http://dx.doi.org/10.1182/bloodadvances.2020003768.
Texto completoBachir Bouiadjra, Chahrazed, Oum Kaltoum Seddiki y Mustapha Bachir Diaf. "Hematologic malignancies in children: Epidemiological aspects in the pediatric oncology department of Oran Anti-Cancerous center, Algeria (2009-2013)". Journal of Drug Delivery and Therapeutics 10, n.º 4 (15 de julio de 2020): 168–74. http://dx.doi.org/10.22270/jddt.v10i4.4248.
Texto completoHagiwara, Shotaro, Yoshinari Suzuki, Akihiro Nakayama, Akihiro Matsunaga, Yutaka Iida y Mari Shimura. "Multiple Elements Classified Hematological Malignancies from Healthy Population". Blood 124, n.º 21 (6 de diciembre de 2014): 5959. http://dx.doi.org/10.1182/blood.v124.21.5959.5959.
Texto completoMeng, Yee Choon, Mervyn Yong Hwang Koh, Zi Yan Chiam, Jun Jun Zhang y Yin Mei, Allyn Hum. "A retrospective review of patients with hematological malignancy referred to an inpatient palliative care service in a tertiary hospital." Journal of Clinical Oncology 35, n.º 31_suppl (1 de noviembre de 2017): 117. http://dx.doi.org/10.1200/jco.2017.35.31_suppl.117.
Texto completoGuilbert, Marie-Christine, Jason L. Hornick, Sona A. Chikarmane y Susan C. Lester. "Hematologic Malignancies of the Breast: A Contemporary Series Investigating Incidence, Presentation, Accuracy of Diagnosis on Core Needle Biopsy, and Hormone Receptor Expression". Breast Cancer: Basic and Clinical Research 13 (enero de 2019): 117822341983098. http://dx.doi.org/10.1177/1178223419830982.
Texto completoWagner, Timothy, Qais Naziri, W. North, Suparna Navale, Alison Klika, Wael Barsoum, Carlos Higuera y Jared Newman. "Hematologic Malignancies Are Associated with Adverse Perioperative Outcomes following Total Knee Arthroplasty". Journal of Knee Surgery 31, n.º 04 (23 de mayo de 2017): 291–301. http://dx.doi.org/10.1055/s-0037-1603335.
Texto completo